Showing results (141-150 of 1,370) with videos related to
Sort By:
Pageof 137
Drug Development Research|August 12, 2017
Small Scaffolds, Big Potential: Developing Miniature Proteins as Therapeutic AgentsJustin M HolubDrug Development Research|March 15, 2016
Neuroprotective Effects of rhGLP-1 in Diabetic Rats with Cerebral Ischemia/Reperfusion InjuryDaoli Jiang, Yitong Wang, Yannan Zang, et al.Drug Development Research|March 15, 2016
Baicalein Induces Caspase-dependent Apoptosis Associated with the Generation of ROS and the Activation of AMPK in Human Lung Carcinoma A549 CellsHong Jae Kim, Cheol Park, Min-Ho Han, et al.Drug Development Research|September 12, 2015
Targeting MicroRNAs in Prevention and Treatment of Neurodegenerative DisordersSmriti Gupta, Savita Verma, Shrikant Mantri, et al.Drug Development Research|September 13, 2015
Targeting c-Met in Cancer by MicroRNAs: Potential Therapeutic Applications in Hepatocellular CarcinomaZeynep F Karagonlar, Peyda Korhan, Neşe AtabeyDrug Development Research|September 30, 2015
Steroid Sulfatase Inhibitors Based on Phosphate and Thiophosphate Flavone AnalogsWitold Kozak, Mateusz Daśko, Maciej Masłyk, et al.Drug Development Research|August 11, 2015
Small Molecules in the Treatment of PsoriasisTiago Torres, Paulo FilipeDrug Development Research|August 28, 2015
The Role of MicroRNAs in the Chemoresistance of Breast CancerJing Wang, Muyi Yang, Yu Li, et al.Drug Development Research|July 25, 2017
Antinociceptive Activity of Ent-Dihydrotucumanoic Acid Isolated from Gymnosperma glutinosum Spreng LessAngel Josabad Alonso-Castro, Marco Martin González-Chávez, Juan Ramón Zapata-Morales, et al.Drug Development Research|July 25, 2017
The Neurotensin NTS1 Receptor Agonist PD149163 Produces Antidepressant-Like Effects in the Forced Swim Test: Further Support for Neurotensin as a Novel Pharmacologic Strategy for Antidepressant DrugsLawrence M Carey, Remington J Rice, Adam J PrusPageof 137